XML 72 R65.htm IDEA: XBRL DOCUMENT v3.25.1
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Sep. 30, 2023
Jul. 24, 2023
Feb. 29, 2024
Mar. 31, 2023
Oct. 31, 2020
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2024
Oct. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Common stock, shares authorized           200,000,000     200,000,000  
Common stock, par value           $ 0.001     $ 0.001  
Stock options to purchase, granted               400,000    
Options shall vested/vest 300,000 100,000                
Shares forfeited 25,000                  
Expenses related to options           $ 41,055 $ 0      
Stock based award, unrecognized compensation expense           131,608        
Stock based award, unrecognized compensation expense           $ 3,179,442        
Stock based award, unrecognized compensation expense, period for recognition           2 years        
Unvested Stock Awards [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Weighted average remaining life (years)           2 years 4 months 28 days        
Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants outstanding           1,768,830        
Issuance of warrants, description           Each warrant provides the holder the right to purchase up to one share of our common stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of common stock at an exercise price of $0.01 per share until December 2026; (2) warrants to purchase 911 shares of common stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,244,108 shares of our common stock at an exercise price of $2.00 per share consisting of 1% of the warrants until August 2024, and 99% until February 2026; and (4) warrants to purchase 386,311 shares of common stock at an exercise price of $2.63 until November 2025.        
Warrant One [Member] | Until April 2025 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           911        
Warrants exercise price           $ 1.65        
Warrant Two [Member] | Expired August 2024 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           1,244,108        
Warrants exercise price           $ 2        
Warrant Four [Member] | Until November 2025 [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           386,311        
Warrants exercise price           $ 2.63        
Warrant Five [Member] | Until December 2026 [ Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Warrants issued to purchase common stock           100,000        
Warrants exercise price           $ 0.01        
2017 Equity Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation shares issuance of equity-based instruments           9,000,000        
Additional shares authorized     3,000,000 1,000,000 4,515,000          
Shares available to issue           3,008,401        
2017 Equity Incentive Plan [Member] | Maximum [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation shares issuance of equity-based instruments                   485,000